KT&G Corporation
033780
Rangering i aksjer
#1565
KT&G Corporation, a diversified South Korean enterprise that operates alongside... KT&G Corporation, a diversified South Korean enterprise that operates alongside its subsidiaries, specializes in a broad array of industries. Its primary business involves the manufacturing and distribution of tobacco products and related materials. Beyond this, the company is a significant provider of health and wellness items, offering red ginseng, various red ginseng-based goods, and other health-focused foods. Its extensive product portfolio also features food and beverage items, along with cosmetic and beauty products. Further diversifying its operations, KT&G offers support services for leaf tobacco cultivation and maintains a presence in the pharmaceutical and medical sectors. This includes the development, production, and supply of pharmaceuticals, encompassing bio-pharmaceuticals, over-the-counter medicines, and a range of medical supplies and equipment. The corporation also holds investments in commercial ventures such as trading, real estate management, property leasing, and housing development. Additionally, it is involved in the development and ongoing management of hotels. Founded in 1987, the company originally operated under the name Korea Tobacco and Ginseng Corporation before officially changing to KT&G Corporation in December 2002. Its corporate headquarters are situated in Daejeon, South Korea.
Aksjekurs
$134.01
Markedsverdi
$13.91B
Endring (1 dag)
-0.10%
Endring (1 år)
38.53%
Land
KR
Handel KT&G Corporation (033780)
Kategori
Consumer Defensive
P/E-forhold for KT&G Corporation (033780)
P/E-forhold per October 2026 TTM: 14.20
Ifølge KT&G Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 14.20. Ved slutten av 2024 hadde selskapet en P/E på 9.47.
P/E-forholdshistorikk for KT&G Corporation fra 2007 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 14.20 | -100.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | 9.47 | -16.86% |
| 2023 | 11.39 | 5.64% |
| 2022 | 10.78 | 7.76% |
| 2021 | 10.00 | 12.18% |
| 2020 | 8.92 | -22.09% |
| 2019 | 11.44 | -15.83% |
| 2018 | 13.60 | 13.40% |
| 2017 | 11.99 | 12.76% |
| 2016 | 10.63 | -15.40% |
| 2015 | 12.57 | 6.17% |
| 2014 | 11.84 | -28.73% |
| 2013 | 16.61 | 21.03% |
| 2012 | 13.73 | 7.37% |
| 2011 | 12.78 | 60.21% |
| 2010 | 7.98 | -17.86% |
| 2009 | 9.71 | -15.80% |
| 2008 | 11.54 | -25.63% |
| 2007 | 15.51 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| - | - |
US
|
|
| 15.43 | 8.67% |
US
|
|
| - | - |
JP
|
|
| 16.73 | 17.80% |
IN
|
|
| 13.40 | -5.65% |
GB
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.